BeOne Medicines (ONC) Total Debt (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.83% |
| Dec 31, 2025 | -38.08% |
| Sep 30, 2025 | 72.45% |
| Jun 30, 2025 | 3.34% |
| Mar 31, 2025 | -9.27% |
| Dec 31, 2024 | -3.17% |
| Sep 30, 2024 | 1.39% |
| Jun 30, 2024 | 1.07% |
| Mar 31, 2024 | 15.80% |
| Dec 31, 2023 | 66.84% |
| Sep 30, 2023 | -15.50% |
| Jun 30, 2023 | 28.76% |
| Mar 31, 2023 | 133.38% |
| Dec 31, 2022 | -67.79% |
| Sep 30, 2022 | 14.74% |
| Jun 30, 2022 | -7.07% |
| Mar 31, 2022 | -3.29% |
| Dec 31, 2021 | -2.11% |
| Sep 30, 2021 | 2.16% |
| Jun 30, 2021 | 5.28% |
| Mar 31, 2021 | 15.31% |
| Dec 31, 2020 | 3,204.99% |
| Sep 30, 2020 | -91.57% |
| Jun 30, 2020 | 99.79% |
| Mar 31, 2020 | 11.88% |
| Dec 31, 2019 | -44.99% |
| Sep 30, 2019 | 62.46% |
| Jun 30, 2019 | -43.19% |
| Mar 31, 2019 | 4.12% |
| Dec 31, 2018 | 218.03% |
| Sep 30, 2018 | -68.69% |
| Jun 30, 2018 | -3.55% |
| Mar 31, 2018 | 5.55% |
| Dec 31, 2017 | 762.13% |
| Sep 30, 2017 | 1.89% |
| Jun 30, 2017 | -11.07% |
| Mar 31, 2017 | 15.16% |
| Dec 31, 2016 | -4.14% |
| Sep 30, 2016 | 70.85% |
| Jun 30, 2016 | 69.83% |
| Mar 31, 2016 | -70.10% |